Quipt Home Medical Corp. (NASDAQ:QIPT – Get Rating) – Equities research analysts at Leede Jones Gab boosted their FY2023 earnings per share (EPS) estimates for shares of Quipt Home Medical in a note issued to investors on Wednesday, January 4th. Leede Jones Gab analyst D. Loe now expects that the company will earn $0.42 per share for the year, up from their previous forecast of $0.19. The consensus estimate for Quipt Home Medical's current full-year earnings is $0.29 per share. Leede Jones Gab also issued estimates for Quipt Home Medical's FY2024 earnings at $0.46 EPS.
Get Quipt Home Medical alerts:Quipt Home Medical (NASDAQ:QIPT – Get Rating) last released its quarterly earnings data on Wednesday, December 21st. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.01. Quipt Home Medical had a return on equity of 7.13% and a net margin of 3.46%. The company had revenue of $40.09 million for the quarter, compared to analyst estimates of $40.50 million.
Several other equities research analysts have also weighed in on the company. Raymond James upped their price objective on Quipt Home Medical from $10.00 to $14.00 and gave the company an "outperform" rating in a research note on Wednesday. Canaccord Genuity Group increased their price target on Quipt Home Medical from C$11.00 to C$11.25 in a research report on Monday, October 24th.Quipt Home Medical Trading Up 0.7 %
QIPT stock opened at $5.58 on Friday. Quipt Home Medical has a 1-year low of $3.89 and a 1-year high of $6.00. The firm has a market cap of $198.68 million, a P/E ratio of 43.31 and a beta of 0.43. The business's 50 day moving average is $4.54 and its 200-day moving average is $4.69. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 0.14.
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the company. Jane Street Group LLC acquired a new stake in Quipt Home Medical during the 2nd quarter worth $47,000. Ritholtz Wealth Management acquired a new stake in Quipt Home Medical during the 3rd quarter worth $48,000. Virtu Financial LLC acquired a new stake in Quipt Home Medical during the 3rd quarter worth $54,000. Royal Bank of Canada raised its stake in Quipt Home Medical by 24.6% during the 1st quarter. Royal Bank of Canada now owns 12,327 shares of the company's stock worth $54,000 after buying an additional 2,437 shares during the period. Finally, Acadian Asset Management LLC raised its stake in Quipt Home Medical by 1,709,900.0% during the 1st quarter. Acadian Asset Management LLC now owns 17,100 shares of the company's stock worth $75,000 after buying an additional 17,099 shares during the period. 26.14% of the stock is currently owned by institutional investors.
About Quipt Home Medical
(Get Rating)
Quipt Home Medical Corp. provides in-home medical equipment and supplies, and respiratory and durable medical equipment in the United States. The company also offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions.
Featured Articles
- Get a free copy of the StockNews.com research report on Quipt Home Medical (QIPT)
- MarketBeat: Week in Review 01/02-01/06
- Why is the CrowdStrike Stock Price Struggling?
- Four Undervalued Healthcare Stocks for 2023
- WWE Stock: Vince McMahon Wants Back In The Show
- NVIDIA Is Bottoming But Don't Buy It Just Yet
Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.